Literature DB >> 6754425

Understanding Cox's regression model.

R Gill.   

Abstract

COX's (1972) regression model has become increasingly popular under many applied statisticians in recent years. On the other hand its use has been attacked on various grounds, the chief of which is that it is supposedly a technique for "data dredging" (which with such a name can obviously not be a good thing). This controversy is sharpened by a lack of understanding on the part of clinicians of what a statistician can do for them, and conversely an inability on the part of statisticians to explain what they can do for the clinician. A final complicating factor is that the methods of statistical analysis advocated by COX (1972) appropriate to his model have been the subject of some mathematical controversy. In this paper we want to explain what the Cox model is and what its place should be in the context of clinical trials. We shall argue that "data dredging", under the name of exploratory data analysis, is a very respectable activity; one which indeed it may be unrespectable not to do. As illustration of the use of the model we refer to the examples in KALBFLEISCH & PRENTICE (1980), MILLER et al. (1980) and KAY (1979). In a section aimed at the mathematical statistician, we draw attention to some recent advances in the mathematics of this subject which should help lessen the controversy surrounding "partial likelihood". It will be apparent to those who attended the 2nd Heidelberg symposium that this paper was prepared after the conference: a previously prepared paper concentrating on the mathematical problems of this subject will appear elsewhere (GILL (1982)). There, a heuristic introduction is given to the counting process approach to censored survival data which we refer to again in the last section. The present paper depends heavily on discussions with, and published and unpublished work by, Niels Keiding, Geert Schou, Bo Pedersen and Per Kragh Andersen (all of the Statistical Research Unit, Copenhagen).

Entities:  

Mesh:

Year:  1982        PMID: 6754425

Source DB:  PubMed          Journal:  Experientia Suppl        ISSN: 0071-335X


  8 in total

1.  Trends in serious infections in rheumatoid arthritis.

Authors:  Orla M Ni Mhuircheartaigh; Eric L Matteson; Abigail B Green; Cynthia S Crowson
Journal:  J Rheumatol       Date:  2013-04-01       Impact factor: 4.666

2.  Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.

Authors:  Marco Bandini; Alberto Briganti; Elizabeth R Plimack; Günter Niegisch; Evan Y Yu; Aristotelis Bamias; Neeraj Agarwal; Srikala S Sridhar; Cora N Sternberg; Ulka Vaishampayan; Christine Théodore; Jonathan E Rosenberg; Joaquim Bellmunt; Matthew D Galsky; Francesco Montorsi; Andrea Necchi
Journal:  Eur Urol Oncol       Date:  2018-09-07

Review 3.  Proportional hazards (Cox) regression.

Authors:  M H Katz; W W Hauck
Journal:  J Gen Intern Med       Date:  1993-12       Impact factor: 5.128

4.  Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy.

Authors:  Marco Bandini; Ariane Smith; Emanuele Zaffuto; Raisa S Pompe; Michele Marchioni; Umberto Capitanio; Felix K Chun; Anil B Kapoor; Shahrokh F Shariat; Francesco Montorsi; Alberto Briganti; Pierre I Karakiewicz
Journal:  World J Urol       Date:  2017-10-11       Impact factor: 4.226

5.  Development and validation of a risk score for serious infection in patients with rheumatoid arthritis.

Authors:  Cynthia S Crowson; Deana D Hoganson; Patrick D Fitz-Gibbon; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2012-09

6.  Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment.

Authors:  Laura R H Ip; George Poulogiannis; Felipe Cia Viciano; Junko Sasaki; Satoshi Kofuji; Victoria J Spanswick; Daniel Hochhauser; John A Hartley; Takehiko Sasaki; Christina A Gewinner
Journal:  Oncotarget       Date:  2015-04-30

Review 7.  The Experimental Oxime K027-A Promising Protector From Organophosphate Pesticide Poisoning. A Review Comparing K027, K048, Pralidoxime, and Obidoxime.

Authors:  Dietrich E Lorke; Georg A Petroianu
Journal:  Front Neurosci       Date:  2019-05-22       Impact factor: 4.677

8.  Identification of hub genes related to CD4+ memory T cell infiltration with gene co-expression network predicts prognosis and immunotherapy effect in colon adenocarcinoma.

Authors:  Lingxue Tang; Sheng Yu; Qianqian Zhang; Yinlian Cai; Wen Li; Senbang Yao; Huaidong Cheng
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.